정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1696 | Recruiting | Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients | Covid-19 | Drug: Antroquinonol Other: Placebo |
Phase 2 | Golden Biotechnology Corporation | INDUSTRY | 174 | All | 18 Years ~ 80 Years | Franciscan Health Michigan City, Michigan City, Indiana, United States Ascension.Via Christi Research, Wichita, Kansas, United States Adventist Healthcare Shady Grove Medical Center, Rockville, Maryland, United States South Jersey Infectious Disease, Somers Point, New Jersey, United States Duke University Southeastern Health, Lumberton, North Carolina, United States Centro Gallego, Buenos Aires, Capital Federal, Argentina Clinica de los Virreyes, Buenos Aires, Capital Federal, Argentina Sanatorio Privado Mayo SA, Cordoba, Ciudad De Cordoba, Argentina Hospital Rawson, Cordoba, Cuidad De Cordoba, Argentina Clinica Viedma SA, Viedma, Pcia De Rio Negro, Argentina Clinica Internacional S.A. - Sede Lima, Lima Cercado, Lima, Peru Unidad de Investigacion, Hospital Nacional IV Alberto Sabogal Sologuren-Essalud, Red Assitencial Sabogal, Callao, Peru Hospital de Chancay, Chancay, Peru Asociacion Civil Selva Amazonica, Iquitos, Peru Hospital III Daniel Alcides Carrion - EsSalud, Tacna, Peru |
| 1695 | Active, not recruiting | Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 | ARDS | Biological: PLX-PAD Biological: Placebo |
Phase 2 | Pluristem Ltd. | INDUSTRY | 66 | All | 40 Years ~ 80 Years | University of California Irvine, Irvine, California, United States University of Southern California (USC) - Keck School of Medicine (KSOM), Los Angeles, California, United States University Of California Davis,4860 Y Street, Sacramento, California, United States Baptist Health Medical Center, Jacksonville, Florida, United States Medical College of Georgia at Augusta University, Augusta, Georgia, United States Sarah Cannon Research Institute, LLC (Mercer University School of Medicine), Macon, Georgia, United States University of Mississippi Medical Center, Jackson, Mississippi, United States Cooper Research Institute, Camden, New Jersey, United States Holy Medical Center, Teaneck, New Jersey, United States Montefiore Medical Center, New York, New York, United States Maimonides Medical Center, New York, New York, United States Mercy Medical Center, New York, New York, United States Thomas Jefferson University, Philadelphia, Pennsylvania, United States |
| 1694 | Recruiting | Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects | Pneumonia, Viral | Drug: Fostamatinib Drug: Placebo |
Phase 3 | Rigel Pharmaceuticals | INDUSTRY | 308 | All | 18 Years ~ 100 Years | University of California Irvine, Orange, California, United States Loyola University Medical School, Maywood, Illinois, United States Harvard Medical School- Bringham and Women's Hospital, Boston, Massachusetts, United States Ascension Medical Group- St. John Clinic Infectious Disease, Tulsa, Oklahoma, United States Providence Portland Medical Center, Portland, Oregon, United States Houston Methodist Research Institute, Houston, Texas, United States Hospital de Alta Complejidad Cuenta Alta, Buenos Aires, Argentina Hospital Del Bicentenario - Dr. Luis Federico Leloir, Buenos Aires, Argentina Clinica Zabala, Buenos Aires, Argentina Clinica Adventista Belgrano, Buenos Aires, Argentina Clinica Monte Grande, Buenos Aires, Argentina Hospital de Infecciosas " Dr.Francisco Javier Muniz", Buenos Aires, Argentina Sanatorio Guemes, Buenos Aires, Argentina Sanatorio Sagrado Corazon, Buenos Aires, Argentina Hospital San Roque, Cordoba, Argentina Sanatorio Mayo Privado, Cordoba, Argentina Hospital das Clinicas da Universidade Federal de Goias (HC/UFG), Goiania, Goias, Brazil Hospital Luxenburgo-Associacao Mario Penna, Belo Horizonte, Minas Gerais, Brazil Hospital Universitario de Maringa, Maringa, Parana, Brazil Irmandade da Santa Casa de Misericordia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande Do Sul, Brazil Complexo de Prevencao, Diagnostico, Terapia e Reabilitacao Respiratoria LTDA, Blumenau, Santa Catarina, Brazil Hospital Alemao Oswaldo Cruz (HAOC), Bela Vista, Sao Paolo, Brazil Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP), Campinas, Sao Paolo, Brazil Hospital Bandeirantes (LeForte), Liberdade, Sao Paolo, Brazil Clinica de Alergia Martti Antila S/S Ltda, Sorocaba, Sao Paulo, Brazil Fundacao Faculdade Reg. de Med de SJRP, Sao Jose Do Rio Preto, Sao Paulo, Brazil Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo Leon, Mexico Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico Nuevo Hospital Civil de Guadalajara, Guadalajara, Mexico Centro Medico Issemym Toluca, Metepec, Mexico The American British Cowdray Medical Center I.A.P., Mexico City, Mexico Hospital Angeles Roma, Mexico, Mexico CEPREP Centro de Prevencion y Rehabilitacion de Enfermedades Pulmonares Cronicas, Nuevo Leon, Mexico Hospital Civil de Culiacan, Sinaloa, Mexico Hospital Civil de Culiacan, Sinaloa, Mexico EsSalud - Hospital Nacional Alberto Sabogal Sologuren, Lima, Peru Hospital de Chancay, Lima, Peru Hospital Maria Auxiliadora, Lima, Peru Hospital Nacional Arzobispo Loayza, Lima, Peru Hospital Nacional Cayetano Heredia, Lima, Peru Hospital Nacional Hipolito Unanue, Lima, Peru |
| 1693 | Completed | Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants | Healthy Participant | Drug: PF-07321332/ritonavir Drug: Itraconazole Drug: PF-07321332/ritonavir |
Phase 1 | Pfizer | INDUSTRY | 12 | All | 18 Years ~ 60 Years | Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Region DE, Belgium |
| 1692 | Recruiting | Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants | Healthy Participants | Drug: Midazolam Drug: PF-07321332/ritonavir + Midazolam Drug: Ritonavir + Midazolam |
Phase 1 | Pfizer | INDUSTRY | 12 | All | 18 Years ~ 60 Years | Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Region DE, Belgium |
| 1691 | Recruiting | Dual MRI for Cardiopulmonary COVID-19 Long Haulers | Covid19 | Drug: Hyperpolarized 129Xenon gas | Phase 2 | Bastiaan Driehuys | OTHER | 30 | All | 18 Years | Duke Asthma, Allergy, and Airway Center, Durham, North Carolina, United States |
| 1690 | Recruiting | Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 | COVID-19 | Drug: Interferon beta-1b Drug: Clofazimine |
Phase 2 | The University of Hong Kong | OTHER | 81 | All | 18 Years | The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong, China |
